Francis P. Barbone

1.5k total citations
16 papers, 629 citations indexed

About

Francis P. Barbone is a scholar working on Molecular Biology, Immunology and Hematology. According to data from OpenAlex, Francis P. Barbone has authored 16 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Immunology and 4 papers in Hematology. Recurrent topics in Francis P. Barbone's work include Erythropoietin and Anemia Treatment (4 papers), CRISPR and Genetic Engineering (3 papers) and Transgenic Plants and Applications (3 papers). Francis P. Barbone is often cited by papers focused on Erythropoietin and Anemia Treatment (4 papers), CRISPR and Genetic Engineering (3 papers) and Transgenic Plants and Applications (3 papers). Francis P. Barbone collaborates with scholars based in United States, Norway and France. Francis P. Barbone's co-authors include Linda K. Jolliffe, Francis X. Farrell, Dana L. Johnson, Frank J. McMahon, Oded Livnah, Ian A. Wilson, E.A. Stura, Nicholas C. Wrighton, William J. Dower and Yun You and has published in prestigious journals such as Journal of Biological Chemistry, Nature Biotechnology and Biochemistry.

In The Last Decade

Francis P. Barbone

16 papers receiving 581 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francis P. Barbone United States 14 323 168 134 121 121 16 629
Balasubramanian Palaniappan United States 11 490 1.5× 178 1.1× 99 0.7× 222 1.8× 136 1.1× 38 854
T W Strickland United States 10 443 1.4× 382 2.3× 57 0.4× 112 0.9× 174 1.4× 10 871
KG Waddick United States 9 342 1.1× 120 0.7× 270 2.0× 153 1.3× 236 2.0× 11 818
Tetsuro Orita Japan 14 1.0k 3.1× 154 0.9× 372 2.8× 98 0.8× 178 1.5× 17 1.3k
Mark O. Showers United States 11 343 1.1× 100 0.6× 93 0.7× 35 0.3× 55 0.5× 15 553
Jean Bowen United States 3 348 1.1× 78 0.5× 69 0.5× 53 0.4× 44 0.4× 4 625
Reinhard Kodym Austria 13 459 1.4× 77 0.5× 169 1.3× 72 0.6× 101 0.8× 29 802
J B Stoudemire United States 11 251 0.8× 108 0.6× 39 0.3× 87 0.7× 139 1.1× 14 564
T Hoang Canada 12 263 0.8× 200 1.2× 158 1.2× 41 0.3× 193 1.6× 23 608
Irma M. Grossi United States 20 598 1.9× 278 1.7× 226 1.7× 54 0.4× 89 0.7× 26 1.3k

Countries citing papers authored by Francis P. Barbone

Since Specialization
Citations

This map shows the geographic impact of Francis P. Barbone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francis P. Barbone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francis P. Barbone more than expected).

Fields of papers citing papers by Francis P. Barbone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francis P. Barbone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francis P. Barbone. The network helps show where Francis P. Barbone may publish in the future.

Co-authorship network of co-authors of Francis P. Barbone

This figure shows the co-authorship network connecting the top 25 collaborators of Francis P. Barbone. A scholar is included among the top collaborators of Francis P. Barbone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francis P. Barbone. Francis P. Barbone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Peet, Norton P., Philip M. Weintraub, Francis P. Barbone, et al.. (2001). THE DESIGN AND SYNTHESIS OF PURINE INHIBITORS OF CDK2. III. Nucleosides Nucleotides & Nucleic Acids. 20(4-7). 1067–1078. 14 indexed citations
2.
Vértesy, László, Francis P. Barbone, Heinrich Decker, et al.. (2001). Pluraflavins, Potent Antitumor Antibiotics from Saccharothrix sp. DSM 12931.. The Journal of Antibiotics. 54(9). 718–729. 19 indexed citations
3.
Middleton, Steven A., Francis P. Barbone, Dana L. Johnson, et al.. (1999). Shared and Unique Determinants of the Erythropoietin (EPO) Receptor Are Important for Binding EPO and EPO Mimetic Peptide. Journal of Biological Chemistry. 274(20). 14163–14169. 47 indexed citations
4.
Barbone, Francis P.. (1999). Plenary lecture. New epoetin molecules and novel therapeutic approaches. Nephrology Dialysis Transplantation. 14(90002). 80–84. 33 indexed citations
5.
Johnson, Dana L., Francis X. Farrell, Francis P. Barbone, et al.. (1998). Identification of a 13 Amino Acid Peptide Mimetic of Erythropoietin and Description of Amino Acids Critical for the Mimetic Activity of EMP1. Biochemistry. 37(11). 3699–3710. 80 indexed citations
6.
Livnah, Oded, Dana L. Johnson, E.A. Stura, et al.. (1998). An antagonist peptide–EPO receptor complex suggests that receptor dimerization is not sufficient for activation. Nature Structural Biology. 5(11). 993–1004. 173 indexed citations
7.
Wrighton, Nicholas C., Balasubramanian Palaniappan, Francis P. Barbone, et al.. (1997). Increased potency of an erythropoietin peptide mimetic through covalent dimerization. Nature Biotechnology. 15(12). 1261–1265. 99 indexed citations
8.
Johnson, Dana L., Francis X. Farrell, Francis P. Barbone, et al.. (1997). Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity. Chemistry & Biology. 4(12). 939–950. 46 indexed citations
9.
Barbone, Francis P., Steven A. Middleton, Dana L. Johnson, et al.. (1997). Mutagenesis Studies of the Human Erythropoietin Receptor. Journal of Biological Chemistry. 272(8). 4985–4992. 14 indexed citations
10.
Johnson, Dana L., Steven A. Middleton, Frank J. McMahon, et al.. (1996). Refolding, Purification, and Characterization of Human Erythropoietin Binding Protein Produced inEscherichia coli. Protein Expression and Purification. 7(1). 104–113. 27 indexed citations
11.
Jolliffe, Linda K., S Middleton, Francis P. Barbone, et al.. (1995). State of the Art Lecture: Erythropoietin receptor: application in drug development. Nephrology Dialysis Transplantation. 10(supp2). 28–34. 24 indexed citations
12.
Barbone, Francis P., et al.. (1992). Yeast killer virus transcription initiation in vitro. Virology. 187(1). 333–337. 5 indexed citations
13.
Barbone, Francis P. & Michael J. Leibowitz. (1991). Coupling of killer virus transcription with translation in yeast cell-free extracts. Journal of General Virology. 72(7). 1755–1760. 1 indexed citations
14.
Leibowitz, Michael J., et al.. (1991). [37] In vitro protein synthesis. Methods in enzymology on CD-ROM/Methods in enzymology. 194. 536–545. 14 indexed citations
15.
Schlesinger, R. Walter, Gary L. Bradshaw, Francis P. Barbone, et al.. (1989). Role of hemagglutinin cleavage and expression of M1 protein in replication of A/WS/33, A/PR/8/34, and WSN influenza viruses in mouse brain. Journal of Virology. 63(4). 1695–1703. 13 indexed citations
16.
Vary, Calvin, Frank J. McMahon, Francis P. Barbone, & Steven Diamond. (1986). Nonisotopic detection methods for strand displacement assays of nucleic acids.. Clinical Chemistry. 32(9). 1696–1701. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026